Neighborhood Features and Genetic Risk Interact to Affect Cognition
A new FAU study is the first to examine how neighborhood environment affects cognition in older adults based on their genetic risk for Alzheimer's disease and dementia.
Researchers Challenge New Guidelines on Aspirin in Primary Prevention
New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70.
Many Teens are Digital Dating Abuse Victims; Boys Get the Brunt of It
It's almost Valentine's Day, but there is nothing romantic about new research illuminating how teen dating abuse is manifesting online. A study explores the problem among U.S. middle and high school à£à£Ö±²¥Ðã.
The Nose Knows: Study Establishes Airborne Exposure to Microcystins
A study explored the link between human nasal and environmental microcystin concentrations from harmful algal blooms and detected the toxin in the nasal passages of 95 percent of the participants.
Oh My Aching Back: Do Yoga, Tai Chi or Qigong Help?
Researchers provide a comprehensive review of the effects of movement-based mind-body interventions on chronic low back pain.
Choosing Common Pain Relievers: It's Complicated
FAU Schmidt College of Medicine researchers examine benefits and risks of nonsteroidal anti-inflammatory drugs to provide guidance to health care providers and their patients in their clinical decision-making.
Publicly Funded Pregnancy à£à£Ö±²¥Ðãs Improve Maternal Mortality Rates
Maternal mortality rates in the United States exceed those of other developed countries, with some considerable racial disparities.
Researchers Take Body Armor to the Next Level with High Energy Fibers
FAU's College of Engineering and Computer Science received $569,482 from Combating Terrorism Technical Support Office to develop advanced fibers to enhance the performance of military helmets and body armor.
Study Shows New Way to Treat Stroke Using an Already FDA-Approved Drug
Researchers from FAU's Schmidt College of Medicine are the first to report on the neuroprotective properties of granulocyte colony-stimulating factor, an already FDA-approved drug.
Genetic Testing in Diverse Young Breast Cancer Patients over a Decade
Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017.